Impact of Cigarette and E-cigarette Menthol Regulation on Current Smokers of Menthol Cigarettes

NCT ID: NCT05896033

Last Updated: 2025-03-05

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Clinical Phase

NA

Total Enrollment

240 participants

Study Classification

INTERVENTIONAL

Study Start Date

2023-10-23

Study Completion Date

2027-08-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

In a 2x2 design, current menthol smokers (N=240) will complete a baseline period before being assigned to a cigarette (menthol or non-menthol) and e-cigarette condition (menthol or tobacco-flavored e-liquid) and receiving a 7-week supply of cigarettes and e-cigarettes. The study builds upon our well-established methodology for simulating tobacco regulatory policies. To model a ban, smokers will be instructed to only use their assigned products. Primary outcomes include cigarette smoking and e-cigarette use during Week 6. However, because a menthol ban may impact the ability to abstain from smoking, the investigators will incentivize participants to abstain from smoking during Week 7 (continued e-cigarette use allowed) and assess the time to first lapse. Participants will complete daily electronic diaries assessing tobacco product use throughout, which will be corroborated by biomarkers for menthol, nicotine, and smoke. Finally, to maximize the utility of these data for FDA regulation, the investigators will assess whether any demographic or baseline smoking characteristics moderate the observed treatment effects, calibrate the treatment effects to the US adult menthol smoking population, and model the effects of menthol regulation in cigarettes and e-cigarettes on smoking and vaping-attributable deaths and life-years lost.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Smoking Prevention and Control

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

FACTORIAL

Primary Study Purpose

PREVENTION

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Menthol Spectrum Cigarettes and Menthol E-cigarettes

Ppts will be randomly assigned to receive the menthol spectrum cigarettes and Njoy Ace menthol e-cigarettes. Will be used for the duration of the study (8 weeks) starting at the second visit.

Group Type EXPERIMENTAL

Menthol Cigarettes

Intervention Type BEHAVIORAL

Ppts will be randomly assigned to a group that receives menthol flavored cigarettes

Menthol Flavored E-cigarettes

Intervention Type BEHAVIORAL

Ppts will be randomly assigned to a group that receives menthol flavored e-cigarettes

Menthol Spectrum Cigarettes and Tobacco E-cigarettes

Ppts will be randomly assigned to receive the menthol spectrum cigarettes and Njoy Ace tobacco e-cigarettes. Will be used for the duration of the study (8 weeks) starting at the second visit.

Group Type EXPERIMENTAL

Tobacco Flavored E-cigarettes

Intervention Type BEHAVIORAL

Ppts will be randomly assigned to a group that receives tobacco flavored e-cigarettes

Menthol Cigarettes

Intervention Type BEHAVIORAL

Ppts will be randomly assigned to a group that receives menthol flavored cigarettes

Non-menthol Spectrum Cigarettes and Menthol E-cigarettes

Ppts will be randomly assigned to receive the non-menthol spectrum cigarettes and Njoy Ace menthol e-cigarettes. Will be used for the duration of the study (8 weeks) starting at the second visit.

Group Type EXPERIMENTAL

Non-Menthol Cigarettes

Intervention Type BEHAVIORAL

Ppts will be randomly assigned to a group that receives non-menthol cigarettes

Menthol Flavored E-cigarettes

Intervention Type BEHAVIORAL

Ppts will be randomly assigned to a group that receives menthol flavored e-cigarettes

Non-menthol Spectrum Cigarettes and Tobacco E-cigarettes

Ppts will be randomly assigned to receive the non-menthol spectrum cigarettes and Njoy Ace tobacco e-cigarettes. Will be used for the duration of the study (8 weeks) starting at the second visit.

Group Type EXPERIMENTAL

Non-Menthol Cigarettes

Intervention Type BEHAVIORAL

Ppts will be randomly assigned to a group that receives non-menthol cigarettes

Tobacco Flavored E-cigarettes

Intervention Type BEHAVIORAL

Ppts will be randomly assigned to a group that receives tobacco flavored e-cigarettes

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Non-Menthol Cigarettes

Ppts will be randomly assigned to a group that receives non-menthol cigarettes

Intervention Type BEHAVIORAL

Tobacco Flavored E-cigarettes

Ppts will be randomly assigned to a group that receives tobacco flavored e-cigarettes

Intervention Type BEHAVIORAL

Menthol Cigarettes

Ppts will be randomly assigned to a group that receives menthol flavored cigarettes

Intervention Type BEHAVIORAL

Menthol Flavored E-cigarettes

Ppts will be randomly assigned to a group that receives menthol flavored e-cigarettes

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

1. adults (21+) who a) have been smoking at least 5 cigarettes daily for one year
2. usual brand (the brand used most often) is mentholated
3. have a smartphone that can receive text messages and access the internet (necessary for diary completion).

Exclusion Criteria

1. other tobacco and pharmacotherapy criteria
2. health and safety criteria
3. planning to move out of the area within the next 3 months
Minimum Eligible Age

21 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

National Institutes of Health (NIH)

NIH

Sponsor Role collaborator

University of Minnesota

OTHER

Sponsor Role collaborator

National Institute on Drug Abuse (NIDA)

NIH

Sponsor Role collaborator

Medical University of South Carolina

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Tracy Smith

Associate Professor-Faculty

Responsibility Role PRINCIPAL_INVESTIGATOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Medical University of South Carolina

Charleston, South Carolina, United States

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

United States

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Tracy T Smith

Role: CONTACT

8437925164

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Tracy Smith, PhD

Role: primary

8437925164

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

1R01DA055985-01A1

Identifier Type: NIH

Identifier Source: secondary_id

View Link

00122898

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Impact of E-cigarette Use on the Body
NCT04972513 ACTIVE_NOT_RECRUITING